1045.15 -0.90 (-0.09%)
910.5K NSE+BSE Volume
BSEJun 14, 2021 11:11 AM
The 15 reports from 7 analysts offering long term price targets for Au Small Finance Bank Ltd. have an average target of 1121.00. The consensus estimate represents an upside of 7.26% from the last price of 1045.15.
|Summary||Date||Stock||Broker||Price at Reco.||Target||Price at reco|
Change since reco(%)
|2021-05-03||Au Small Finance Ban.. +||HDFC Securities||924.05||1056.00||924.05 (13.11%)||Target met||Accumulate|
HSIE Results Daily: IndusInd Bank, Shriram Transport Finance, AU Small Finance Bank, Trent, Ajanta Pharma, Motilal ...
Ajanta Pharma: Ajanta delivered solid Q4 with revenue/EBITDA growth of 11%/71% YoY amidst challenging environment. While revenues came in line, strong recovery in India (+23% YoY) and continued growth in the US (+21% YoY) was encouraging. EBITDA margin improved to 34.3% (+200bps QoQ) driven by higher gross margin and lower other expenses. We expect margin to stabilize around ~31%+ levels in FY22 (vs. 26%/34% in FY20/21) as other expenses normalise. With conclusion of major capex and steady growth in key markets, operating leverage benefit is expected to drive ~13% earnings CAGR over FY21-23e and core ROCE expansion to 28% in FY23 (from ~17%/25% in FY20/21). Maintain BUY. Revised TP of INR2,225/sh. Motilal Oswal Financial Services: Strong cash/derivative volume at +19/20% QoQ drove capital markets APAT +114/12% YoY to INR 917mn. AMC's APAT grew 86/65% to INR 746mn (+73% vs. est.) on the back of healthy equity markets and certain one-offs. Significant MTM gain (INR 2.6bn, +25% QoQ) on treasury resulted in MOFS (ex. MOHFL) APAT growth of 31% sequentially to INR 4.3bn. We have increased our FY22/23E estimates to factor in lower impact of peak-margin requirements. We retain an ADD with a TP of INR 800 (15/25x Mar-23E Broking/AMC APAT, + 0.7/0.5x for Mar-23E treasury/ MOHL). IndusInd Bank: IndusInd Banks (IIB) 4QFY21 operating performance was above our expectations (PPOP growth of 8% YoY), marred by higher-than-expected provisions. While the bank continues to gain traction on deposits mobilisation (27% YoY), it seems to be conservative on assets mobilisation (loan growth of 3% YoY) with greater focus on...
|2021-05-03||Au Small Finance Ban.. +||Axis Direct||924.05||1105.00||924.05 (13.11%)||5.73||Buy|
|2021-05-02||Au Small Finance Ban.. +||Motilal Oswal||924.05||1175.00||924.05 (13.11%)||12.42||Buy|
AUBANK reported a weak 4QFY21, with earnings impacted by one-offs in the form of higher interest reversals and increase in opex, led by ESOPrelated expenses. However, business momentum was robust, with retaildeposit mix improving further. Asset quality developments: GNPA/NNPA increased to 4.3%/2.2%, led by tagging of customers who are less than 90dpd and paying, but was once NPA ('ONAN') during prior quarters. However, CE and customer activation rate moved higher than pre-COVID levels. We remain watchful of asset quality in the near term and cut our FY22E/FY23E earnings by 20%/17% to factor in higher credit cost. Maintain Buy....
|2021-05-01||Au Small Finance Ban.. +||BOB Capital Markets Ltd.||924.05||1300.00||924.05 (13.11%)||24.38||Buy|
|2021-04-07||Au Small Finance Ban.. +||BOB Capital Markets Ltd.||1174.50||1500.00||1174.50 (-11.01%)||43.52||Buy|
BOB Capital Markets Ltd.
We expect AU Small Finance Bank's (AUBANK) longstanding expertise in vehicle finance and successful extension into secured business loans to aid a 22% loan CAGR over FY20-FY23.
|2020-10-30||Au Small Finance Ban.. +||Axis Direct||775.35||872.00||775.35 (34.80%)||Target met||Buy|
We remain confident in the bank's ability to bounce back and gather growth momentum as the macro economic conditions normalise. We maintain a BUY rating on the stock with a price target of Rs 872 (4.25x Sept'22E ABV).
|2020-10-29||Au Small Finance Ban.. +||HDFC Securities||775.35||775.35 (34.80%)||Results Update|
We maintain ADD with a target price of Rs 770. AUBANKs 2QFY21 net earnings were ~110% ahead of estimates, buoyed by gains from the stake sale in AAVAS. Adjusted earnings, too, were ~28% ahead of estimates, on account of lower-than-expected provisions. The bank saw a sustained improvement in collection efficiency and did not make incremental COVID-19 related provisions. While these trends are promising, we continue to model for a sharp rise in GNPAs and elevated provisions in FY21E. Strong CASA growth, led by retail deposits, was another positive. We like the bank for its strong fundamentals and believe that its long-term prospects remain intact.
|2020-09-14||Au Small Finance Ban.. +||Axis Direct||700.90||835.00||700.90 (49.12%)||Target met||Buy|
Asian markets are trading higher as investors focus on developments of the coronavirus vaccine after AstraZeneca resumed its phase-3 trial, while sentiments remain cautious ahead of the central bank meeting in the UK, Japan and the U.S during the week. Nikkei is trading higher by 0.71%; Hang Seng is
|2020-07-24||Au Small Finance Ban.. +||HDFC Securities||791.30||724.00||791.30 (32.08%)||Target met||Accumulate|
We maintain our ADD rating with a revised target price of Rs 724.) AUBANKs 1QFY21 net earnings were 52% higher than estimates, driven by a sharp fall in operating expenditure and high treasury gains. The reduction in moratorium or improvement in collection efficiency and retail deposit traction were promising. We continue to believe that AUBANK is one of the best-placed SFBs due to its relatively better deposit franchise, largely secured book, and strong execution track record. Strong fundamentals and adequate opportunity bode well for the banks long-term growth prospects
|2020-07-24||Au Small Finance Ban.. +||Yes Securities||785.65||785.65 (33.03%)||Buy|
|2020-05-28||Au Small Finance Ban.. +||HDFC Securities||398.10||549.00||398.10 (162.53%)||Target met||Accumulate|
Banks' core spreads and NIMs are likely to compress in the near term. Our stance is premised on the following, (1) faster growth in high yielding segments which supported WALR (o/s) is likely to slow, this may be inferred from by the sharp dip in WALR (fresh) which has dipped sharply in Mar-20, (2) the effects of lower MCLRs will become more pronounced, (3) external benchmark-linked loans will see a significant fall in yields and a gradual rise in share and (4) slower re-pricing of liabilities will limit benefits of lower TD rates although, SA rate cuts will provide some cushion here. Over FY20 so far, weve seen divergent NIM trends, but most of our coverage banks saw NIM improve. The drivers of movement on either sides, however, varied vastly.
|2020-05-18||Au Small Finance Ban.. +||HDFC Securities||396.95||549.00||396.95 (163.30%)||Target met||Buy|
Additional clarity on the moratorium front will emerge in 1QFY21E and that on anticipated asset quality outcomes will emerge when lockdown measures ease. We've increased our provision estimates for most of our coverage banks this qtr. Our existing thesis on the sector remains as is. Banks, with strong granular liability franchises, reasonable asset quality performance, lesser exposure to vulnerable segments and sufficient capital are likely to emerge stronger. We prefer ICICIBC and AXSB amongst the larger banks and CUBK amongst the smaller banks. Additional disclosures and management commentary provide an interesting (and varying) perspective of the on-ground situation and potential impact of COVID-19 on the sector. Key takes from additional disclosures and commentary include- (1) borrowers representing ~25-71% of loans (which have declared results till 14-May-20) have availed moratorium as per the RBIs 27-Mar-20 circular, (2) several banks made provisions, in addition to the RBI mandated provisions, based on their assessment of the potential impact of COVID-19, but the relative quantum varied vastly, (3) most banks shored up their PCR (partly optical due to the standstill classification benefit), and (4) many hinted at measures to bring down costs in FY21E and halt/ slow branch expansion plans.
|2020-05-04||Au Small Finance Ban.. +||HDFC Securities||491.20||549.00||491.20 (112.77%)||Target met||Sell|
Post the sharp correction, we upgrade to ADD (TP of Rs 549, 3.3x FY22E ABV+ Rs 14 for the residual AAVAS stake). AUBANK saw strong b/s growth in 4QFY20, amidst a challenging external environment. As with other banks, AUBANKs PAT was hit by higher provisions. AUBANK is better-placed vs. its SFB peers on assets quality (largely secured book) and liability franchise (granular deposits). Given the systemic issues, we believe mid-tier banks (particularly SFBs) will face challenges in deposit mobilisation, in addition to higher stress. Dwindling competition from NBFCs, high CRAR, and a credible execution track record underpin our positive stance.
|2020-05-04||Au Small Finance Ban.. +||Motilal Oswal||491.20||675.00||491.20 (112.77%)||Target met||Buy|
4 May 2020 AU Small Finance Bank (AUBANK) reported subdued earnings, impacted by higher provisions (INR1.4b) toward SMA accounts. Overdue loans stood at INR23b (8.5% of loans) as of April20 v/s INR36b as of 1 Mar20. 29% of customers (25% of the loan book) availed moratorium, which would be the key monitorable in the near term. On the business front, loan growth moderated, while deposits stood healthy. We cut our earnings estimate for FY21/22 by 18%/10% as we factor in high credit cost and moderation in business growth. AUBANK reported 3.5% YoY growth in PAT to INR1.2b, affected by higher provisions of INR1.5b, as it made ~5% provisions (INR1.4b) toward SMA accounts, as per an RBI circular. NII grew 43% YoY (+10% QoQ) to INR5.5b NII/PPoP/PAT grew 42%/66%/77% respectively while core PPoP/adjusted PAT (adjusted for stale sale in Aavas) grew 57%/56% respectively.
|2020-04-20||Au Small Finance Ban.. +||HDFC Securities||29.65||509.00||29.65 (3424.96%)||Target met||Sell|
Consequently, we prefer ICICIBC, AXSB and KMB amongst the large caps. We prefer CUBK amongst the pack of smaller regional banks. We maintain our REDUCE rating on RBK and KVB, despite their sharp underperformance. Recent events (YES and COVID-19) are likely to have multiple order and far reaching impacts on the banking sector. COVID-19 will obviously impact growth and asset quality. The events at YES have impacted depositor sentiment, causing them to become more risk-averse, we believe. Consequently, the less obvious (but equally important) impact is expected to play out on the liabilities side. In such a scenario, we believe deposit flows will become more polarised. Larger banks, with strong granular liability franchises, reasonable asset quality performance and sufficient capital are likely to emerge stronger.
|2020-01-24||Au Small Finance Ban.. +||Chola Wealth Direct||1070.70||1060.00||1070.70 (-2.39%)||Target met||Hold|
Chola Wealth Direct
Background: AU SFB, initially incorporated as a vehicle finance company in 1996, was transformed into a Small Finance Bank in April 2017. The bank has presence in 11 states and 1 union territory, with 496 branches, 310 ATMs, 31 asset centers and ~6,59,904 loan accounts. The bank offers a comprehensive and tailor made range of products (both asset and liability) and services to cater to the needs of various businessmen (SME and MSME) and other middle and low...
|2020-01-23||Au Small Finance Ban.. +||HDFC Securities||974.55||866.00||974.55 (7.24%)||Target met||Neutral|
We reiterate that AUBANK represents the virtues of both a bank and an NBFC. The bank's ability to deliver strong operating performance across parameters in a challenging environment, (with considerable consistency, esp. over the trailing 3 qtrs) increases our confidence on RoAE improvement at the bank. However, in view of lofty valuations (6.5x Mar-21E), esp. after the recent run-up (48% since Sept-19), we downgrade the stock to NEUTRAL. While the mgt has indicated that the bank could raise CET 1 in FY21, we have not built this. AUBANKs 3QFY20 performance exceeded our estimates across all fronts. While we remain admirers of AUBANKs strong fundamentals and business potential, were compelled to downgrade to NEUTRAL, post the recent run up. TP of Rs 866 (4.75x Dec-21E core ABV of Rs 177 + Rs 23/sh for the residual AAVAS stake).
|2019-12-24||Au Small Finance Ban.. +||Motilal Oswal||784.50||784.50 (33.22%)||Mgmt Note|
AUBANKs focus remains more on self-employed customers to grow its asset business supported by improving speed of execution. Average balances are INR25-30k in SA, INR110k-120k in CA and INR1.0-1.2m in FDs. Average productivity stands at ~12-15 new accounts opened per month per bank officer. AUBANK offers 28 products to customers across branches, majority of which are asset products. Asset book is gaining scale and the bank recently witnessed one of the strongest months for disbursement since inception. The bank mainly focuses on small-ticket-size loans, which provides granularity to the portfolio and ensures stable asset quality. Average ticket size is INR1.0-INR1.2m and the same has moderated over past one year as AUBANK further tightened its lending standard to maintain healthy asset quality amidst a slowing economy. Nearly 85% of vehicles are sold on finance customers themselves arrange for the loan in 15% of these cases. HDFCB and SBIN together account for ~50% of the total vehicles sold on financing.
|2019-11-13||Au Small Finance Ban.. +||Chola Wealth Direct||808.15||793.00||808.15 (29.33%)||Target met||Neutral|
Chola Wealth Direct
Sector: Banks/Mid Cap | Earnings Update 2QFY20 Background: AU SFB, initially incorporated as a vehicle finance company in 1996, was transformed into a Small Finance Bank in April 2017. The bank has its presence in 11 states and 1 union territory, with 428 branches, 565 ATMs, 78 asset centers and ~5,92,929 loan accounts. The bank offers a comprehensive and tailor made range of products (both asset and liability) and services to cater to the needs of various businessmen (SME and MSME) and other middle and low...
|2019-10-22||Au Small Finance Ban.. +||HDFC Securities||689.25||807.00||689.25 (51.64%)||Target met||Buy|
We like AUBANK's ability to sustain quality growth, particularly in challenging environs. This, we believe, is reflective of its NBFC roots even as it gains from the troubles faced by erstwhile peers. Improvement in oplev this qtr beat estimates, and will be key to RoAA improvement. While asset quality remains stable, the bank's NBFC/RE exposure does hold some risk. Superior return ratios and improving performance across metrics warrant premium multiples. Yet again, AUBANK ticked most boxes (growth, C-I, asset quality and NIMs) with its 2QFY20 performance. Contextually, AUBANKs forward march looks even better, when peers are struggling on one or other aspect. MAINTAIN BUY with a TP of Rs 807 (4.75x Sep-21E core ABV of Rs 166 + Rs 19/sh for the residual AAVAS stake).